SCHEMBL19981413

SCHEMBL19981413

CCOC(=O)/C=C/C(=O)Nc1cc(C)nc(C)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 10/20 0.56
LMNA P02545 6/20 0.56
ALDH1A1 P00352 6/20 0.56
THRB P10828 1/20 0.56
KMT2A Q03164 5/20 0.54
MEN1 O00255 4/20 0.54
NPC1 O15118 1/20 0.54
HSP90AA1 P07900 1/20 0.54
PKM P14618 1/20 0.54
HPGD P15428 1/20 0.54
CCR6 P51684 1/20 0.54
NPSR1 Q6W5P4 1/20 0.54
APOBEC3G Q9HC16 1/20 0.54
MDM2 Q00987 1/20 0.54
HTT P42858 1/20 0.53
POLB P06746 1/20 0.50
AURKA O14965 1/20 0.49
EGFR P00533 2/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
HCAR2 Q8TDS4 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19981476 0.83 KMT2A (0.56) MAPTLMNAALDH1A1THRBKMT2A
SCHEMBL20129339 0.82 MAPT (0.76) MAPTLMNAALDH1A1THRBKMT2A
SCHEMBL20129849 0.82 MAPT (0.76) MAPTLMNAALDH1A1THRBKMT2A
SCHEMBL20129478 0.82 MAPT (0.76) MAPTLMNAALDH1A1THRBKMT2A
SCHEMBL19974185 0.79 ALDH1A1 (0.59) MAPTLMNAALDH1A1THRBKMT2A
SCHEMBL19974183 0.79 ALDH1A1 (0.59) MAPTLMNAALDH1A1THRBKMT2A
SCHEMBL19981480 0.79 MAPT (0.63) MAPTLMNAALDH1A1THRBKMT2A
SCHEMBL20129821 0.78 MAPT (0.70) MAPTLMNAALDH1A1THRBKMT2A
SCHEMBL10877147 0.78 MAPT (0.79) MAPTLMNAALDH1A1THRBKMT2A
SCHEMBL17789566 0.78 ALDH1A1 (0.62) MAPTLMNAALDH1A1THRBKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3512602-B1 INHIBITORS OF HEAT SHOCK FACTORS (HSF) AND USES THEREOF HSF PHARMACEUTICALS (CH) 2024-03-27 EP disclosed
US-11597708-B2 Inhibitors of heat shock factors and uses thereof HSF PHARMACEUTICALS SA (CH) 2023-03-07 US disclosed
US-11597708-B2 Inhibitors of heat shock factors and uses thereof HSF PHARMACEUTICALS SA (CH) 2023-03-07 US disclosed
US-20210221778-A1 Inhibitors of heat shock factors and uses thereof HSF PHARMACEUTICALS SA (CH) 2021-07-22 US disclosed
US-20210221778-A1 Inhibitors of heat shock factors and uses thereof HSF PHARMACEUTICALS SA (CH) 2021-07-22 US disclosed
WO-2018050656-A2 INHIBITORS OF HEAT SHOCK FACTORS AND USES THEREOF HSF PHARMACEUTICALS (CH) 2018-03-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11597708-B2 Inhibitors of heat shock factors and uses thereof HSF1, HSP90AB2P, HSP90AB1 MAPT 2930/4885LMNA 3549/4885ALDH1A1 2641/4885
US-20210221778-A1 Inhibitors of heat shock factors and uses thereof HSF1, HSP90AB2P, HSP90AB1 MAPT 2930/4885LMNA 3549/4885ALDH1A1 2641/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.